This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.

Revoke all U.S. patents based on Cannabis, or reschedule Cannabis from Schedule I of the Controlled Substances Act.

Created by S.C. on February 01, 2013

It is insulting to the people of the United States to continue to say the cannabis plant has no medical benefits while issuing medical based patents from cannabis research. Currently cannabis is listed as a Schedule I substance under the Controlled Substances Act.
Schedule I substances are those that have the following characteristics,
-The drug or other substance has no currently accepted medical use in treatment in the United States.

At the same time at least one patent showing the medical benefits of cannabis, U.S. patent #6,630,507, exists. This is a clear contradiction of the stance taken under the Controlled Substances Act. Simple solutions, pick one, revoke or reschedule.

Energy & Environment
Civil Rights & Equality
Government & Regulatory Reform
Return to top